123
Participants
Start Date
February 27, 2019
Primary Completion Date
January 15, 2021
Study Completion Date
August 30, 2021
elezanumab
solution for infusion
placebo
solution for infusion
Duplicate_Parexel International /ID# 202747, Baltimore
Integrated Neurology Services /ID# 202743, Alexandria
West Virginia Univ School Med /ID# 202849, Morgantown
Advanced Neurosciences Institute /ID# 204555, Franklin
Michigan Institute for Neurological Disorders (MIND) /ID# 202470, Farmington Hills
Washington University-School of Medicine /ID# 202899, St Louis
Rowe Neurology Institute /ID# 202744, Lenexa
Oklahoma Med Res. Foundation /ID# 203442, Oklahoma City
Central Texas Neurology Consul /ID# 203108, Round Rock
Advanced Neurosciences Research, LLC /ID# 203072, Fort Collins
St. Josephs Hospital and Med Center /ID# 202809, Phoenix
Virginia Mason Medical Center /ID# 205439, Seattle
Sutter East Bay Medical Foundation-Jordon Research and Education Dev. Inst. /ID# 202448, Berkeley
The Research Center of Southern California /ID# 202802, Carlsbad
Vladimir Royter MD /ID# 202483, Hanford
Stanford MS Center /ID# 202445, Palo Alto
UC Davis Health-Neurological Surgery /ID# 202485, Sacramento
UCSF School of Medicine - Neurology /ID# 203194, San Francisco
University of Colorado School of Medicine, Dept of Neurology /ID# 202807, Aurora
International Neurorehabilitation Institute /ID# 213333, Lutherville
Memorial Neurological Institute and Center for Multiple Sclerosis /ID# 206327, Owosso
Ridgeview Specialty Clinic Chaska - Neurology /ID# 204384, Chaska
The MS Center for Innovations in Care at Missouri Baptist Medical Center /ID# 205432, St Louis
Cleveland Clinic Lou Ruvo Cent /ID# 204744, Las Vegas
Providence Neurological Specialties - West /ID# 203193, Portland
KCA Neurology - Franklin /ID# 202912, Franklin
Neurology Consultants of Dallas - LBJ Fwy /ID# 203102, Dallas
Evergreen Neuroscience Institute /ID# 204205, Kirkland
Swedish MS Center /ID# 202904, Seattle
Froedtert Memorial Lutheran Hospital /ID# 202618, Milwaukee
University of British Columbia - MS & NMO Clinical Trials Group, Djavad Mowafagh /ID# 203536, Vancouver
Duplicate_London Health Sciences Centre - University Hospital /ID# 203538, London
Ottawa Hospital Research Institute /ID# 203058, Ottawa
Unity Health Toronto - St. Michael's Hospital /ID# 206213, Toronto
Recherche Sepmus Inc. /ID# 212852, Greenfield Park
Centre Hospitalier de l'Universite de Montreal - CRCHUM /ID# 203869, Montreal
Montreal Neurological Institut /ID# 203868, Montreal
Lead Sponsor
AbbVie
INDUSTRY